THE IMPORTANCE OF HBA1C EVOLUTION IN COST-EFFECTIVENESS MODELING OF TYPE 2 DIABETES MELLITUS (T2DM)

被引:0
|
作者
Willis, M. [1 ]
He, J. [2 ]
Neslusan, C. [2 ]
Johansen, P. [1 ]
Worbes-cerezo, M. [3 ]
机构
[1] Swedish Inst Hlth Econ, Lund, Sweden
[2] Janssen Global Serv LLC, Raritan, NJ USA
[3] Janssen Cilag SA, Madrid, Spain
关键词
D O I
10.1016/j.jval.2012.08.1683
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A500 / A500
页数:1
相关论文
共 50 条
  • [1] Modelling HbA1c Trajectory in Patients with Type 2 Diabetes Mellitus (T2DM)
    Mcewan, Phil
    Fellows, Jonathan
    Yapp, Rhiannon
    Bergenheim, Klas
    Qin, Lei
    Varol, Nebibe
    Bennett, Hayley
    Gordon, Jason
    [J]. DIABETES, 2016, 65 : A322 - A322
  • [2] Clustering of HBA1C longitudinal trajectories in type 2 diabetes mellitus (T2DM)
    De la Torre, Adrian Martinez
    Faquetti, Maria Luisa Marques De Sa
    Perez-Cruz, Fernando
    Weiler, Stefan
    Burden, Andrea
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 60 - 60
  • [3] Implications of Using the UKPDS HbA1c Equation in Economic Modeling of Type 2 Diabetes Mellitus (T2DM)
    Willis, Michael
    Asseburg, Christian
    Johansen, Pierre
    Schroeder, Melanie
    Neslusan, Cheryl
    [J]. DIABETES, 2016, 65 : A581 - A581
  • [4] Abnormally low HbA1c in type 2 diabetes mellitus (T2DM): Familiar study
    Gargallo, Manuel A.
    Familiar, Cristina
    Gonzalez, Fernando A.
    Villegas, Ana
    [J]. DIABETES, 2006, 55 : A112 - A113
  • [5] HbA1c and Prediction of Type 2 Diabetes (T2DM) in Children and Adults
    Vijayakumar, Pavithra
    Nelson, Robert G.
    Hanson, Robert L.
    Knowler, William C.
    Sinha, Madhumita
    [J]. DIABETES, 2016, 65 : A65 - A65
  • [6] Initial HbA1c and HbA1c Lowering: Implications for Model-Based Economic Evaluations in Type 2 Diabetes Mellitus (T2DM)
    Willis, Michael
    Neslusan, Cheryl
    Asseburg, Christian
    He, Jianming
    [J]. DIABETES, 2011, 60 : A68 - A68
  • [7] Treatment Progression and Impact of HbA1C in Type 2 Diabetes (T2DM) Patients
    Dibello, Julia R.
    Levy, Brian
    Mehra, Maneesha
    [J]. DIABETES, 2010, 59 : A623 - A624
  • [8] IMPACT OF PATIENT WEIGHT TRAJECTORY ON COST-EFFECTIVENESS OF TREATMENTS OF TYPE 2 DIABETES MELLITUS (T2DM)
    Schroeder, M.
    Willis, M.
    Johansen, P.
    Girod, I
    Neslusan, C.
    Thompson, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A440 - A440
  • [9] THE COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN COMBINATION WITH INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
    Sanchez-Covisa, J.
    Capel, M.
    Schmidt, R.
    Charokopou, M.
    Verheggen, B. G.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A350 - A350
  • [10] THE EFFECT OF TREATMENT INTENSIFICATION ASSUMPTIONS ON ESTIMATES OF COST-EFFECTIVENESS IN TYPE 2 DIABETES MELLITUS (T2DM)
    Willis, M.
    Johansen, P.
    Neslusan, C.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A62 - A62